In-Person vs. Virtual Therapy for Postpartum Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines whether a group therapy program for preventing postpartum depression is as effective online as it is in person. The therapy, known as the ROSE Program (Reach Out, Stay Strong, Essentials for mothers of newborns), supports new mothers with social support and communication skills and is available in both English and Spanish. The trial suits pregnant women who are less than 30 weeks along and wish to explore different ways to manage their mental health after giving birth. Participants can choose to attend sessions in person or via Zoom. As an unphased trial, this study provides a unique opportunity for participants to explore innovative mental health support options during a crucial time.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the ROSE Program, available both in person and online, helps prevent postpartum depression (PPD) in new mothers. This program teaches skills and provides information to lower the risk of PPD. Studies have found that participants well-receive the in-person version of the ROSE Program, finding the sessions helpful for managing emotional changes after childbirth.
The online version of the ROSE Program mirrors the structure of the in-person one. Although newer, the online sessions aim to offer the same support and benefits. So far, no specific negative effects have been reported for either version of the program.
Overall, both in-person and online sessions of the ROSE Program are considered safe based on current information. Participants usually find the program helpful and practical for supporting their mental health after having a baby.12345Why are researchers excited about this trial?
Researchers are excited about the ROSE Program for postpartum depression because it offers flexibility and accessibility that current treatments might lack. Unlike traditional in-person therapy sessions, the ROSE Program includes a virtual delivery option, making it easier for new mothers to participate from home via Zoom. This dual approach not only provides the same content and support as in-person therapy but also reduces barriers such as transportation challenges, particularly through the provision of Uber rides for those attending in person. The program's focus on social support, communication, and role transition to motherhood addresses key areas that can significantly impact postpartum depression outcomes. This innovative blend of accessibility and comprehensive support is what sets the ROSE Program apart from standard care options.
What evidence suggests that this trial's treatments could be effective for postpartum depression?
Research has shown that the ROSE Program, when conducted in person, helps prevent postpartum depression. This program supports new mothers by focusing on social support, adjusting to their new role, improving communication skills, and teaching about postpartum depression. Studies have found that women who attend in-person ROSE sessions experience lower rates of depression after having a baby.
This trial tests the online version of the ROSE Program as a separate treatment arm to determine its effectiveness compared to in-person sessions. Early results suggest that virtual sessions can also provide the support and education needed to help prevent postpartum depression. Offering the program online may make it easier for more women to access this important support from home.12346Who Is on the Research Team?
Galena Rhoades, PhD
Principal Investigator
University of Denver
Elysia P Davis, PhD
Principal Investigator
University of Denver
Are You a Good Fit for This Trial?
This trial is for English or Spanish-speaking individuals who are less than 30 weeks into their pregnancy. It's designed to help prevent postpartum depression and there are no specific exclusion criteria, meaning it's quite open for participants.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the ROSE program, consisting of four 90-minute weekly group sessions and one individual booster session, delivered either in-person or virtually
Follow-up
Participants are monitored for depression levels using surveys and electronic health records at multiple time points postpartum
What Are the Treatments Tested in This Trial?
Interventions
- ROSE Program: In Person
- ROSE Program: Virtual
ROSE Program: In Person is already approved in United States for the following indications:
- Prevention of postpartum depression
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Denver
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
Denver Health Medical Center
Collaborator